You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
華森製藥(002907.SZ):兩高管提前終止減持計劃 劉小英已減持290.48萬股
格隆匯 01-15 12:00

格隆匯1月15日丨華森製藥(002907.SZ)公佈,公司近日分別收到持股5%以上股東、董事、高管劉小英及高管彭曉燕出具的《關於提前終止減持計劃的吿知函》,劉小英及彭曉燕決定提前終止實施此次股份減持計劃。

其中,劉小英於2020年12月17日-2021年1月14日期間通過集中競價方式減持公司股份290.48萬股,佔公司總股本的0.7231%;而彭曉燕未通過任何方式減持公司股份。

據悉,劉小英原擬自2020年8月29日起15個交易日後的6個月內以集中競價或大宗交易方式減持公司股份不超過370萬股,即不超過公司總股本的0.9210%;彭曉燕原擬自2020年8月29日起15個交易日後的6個月內以集中競價方式減持公司股份不超過1.25萬股,即不超過公司總股本的0.0031%。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account